Concepedia

Michael Hayes

MH

Statistics

Publications

72

Citations

5.3K

H-Index

36

Active since

1955

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

University of Michigan

Oregon Health & Science University

Illinois State University

Michael Hayes is an author at Novartis (Switzerland) specializing in pharmacology, pharmacy, and medicine.

Publications per year

1955–2022

72

Publications

72

Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial With Chronic Myeloid Leukemia Patients

Bin Peng, Michael Hayes, Debra Resta et al. · Journal of Clinical Oncology · 2004 · 470 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

Patrick Y. Wen, W.K. Alfred Yung, Kathleen R. Lamborn et al. · Clinical Cancer Research · 2006 · 432 citations

Medicine, Pharmacokinetics, Pharmacology +16

Isolation and Structural Identification of 1,25- Dihydroxyvitamin D<sub>3</sub>Produced by Cultured Alveolar Macrophages in Sarcoidosis*

John S. Adams, Frederick R. Singer, Mercedes A. Gacad et al. · The Journal of Clinical Endocrinology & Metabolism · 1985 · 287 citations

Life Sciences, Biochemistry, Endocrinology +17

Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux

Haiqing Dai, Peter Marbach, Michel Lemaire et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 272 citations

Medicine, Pharmacokinetics, Pharmacology +17

METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS

Hans-Peter Gschwind, Ulrike Pfaar, Felix Waldmeier et al. · Drug Metabolism and Disposition · 2005 · 221 citations

Medicine, Pharmacokinetics, Pharmacology +15

1–5 of 72